<DOC>
	<DOCNO>NCT00071253</DOCNO>
	<brief_summary>The purpose study assess efficacy safety continue combination therapy use Depakote plus olanzapine , vs. Depakote monotherapy olanzapine monotherapy stable subject maintenance phase bipolar illness .</brief_summary>
	<brief_title>Depakote Monotherapy , Olanzapine Monotherapy , Combination Therapy Depakote Plus Olanzapine Stable Subjects During Maintenance Phase Bipolar Illness</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>DSMIVTR primary diagnosis Bipolar I Disorder confirm SCID Outpatient receive treatment combination Depakote plus olanzapine bipolar illness consider clinically stable ( e.g. , minimal symptom , psychiatric hospitalization , increase intensity clinical intervention ) precede 4 month Identified Screening bothersome side effect list UKU make switch monotherapy desirable MRS total score &lt; 12 two consecutive rating , separate least 5 day ( Screening Day 1 ) DSS score &lt; 13 two consecutive rating , separate least five day ( Screening Day 1 ) CGIS score &lt; 3 two consecutive rating , separate least five day ( Screening Day 1 ) Serum valproate level &gt; 45 mcg/mL , maximum allowable dose Depakote 3000 mg/day Screening Olanzapine dose 5 20 mg/day Screening History schizophrenia schizoaffective disorder Axis I ( e.g. , anxiety disorder ) Axis II ( e.g. , personality disorder ) would interfere compliance confound interpretation study result Has take antipsychotic , mood stabilizer , anticonvulsant ( unless specifically seizure control ) Depakote olanzapine four month prior randomization . Other psychotropics ( e.g. , antidepressant , anxiolytic ) exception stimulant , use routinely maintain stability precede four month may continue , increase decrease Has first manic episode age 60 Has ever take clozapine Has receive depot neuroleptic medication within six month randomization Urine toxicology screen positive phencyclidine ( PCP ) , opiates , cocaine amphetamine History active alcohol substance abuse/dependence within 90 day prior Screening Known history nonresponse either Depakote olanzapine monotherapy treatment bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Bipolar Disorder - Mania</keyword>
</DOC>